“…Recently, a novel subset of CD8 T cells, CXCR5 + CD8 + T cells, were identified [ 141 – 143 ]. CXCR5 + CD8 + T cells have been found to infiltrate the B cell follicle in response to several diseases, including viral infection (simian immunodeficiency virus (SIV) or human immunodeficiency virus (HIV) [ 144 – 170 ], lymphocytic choriomeningitis virus (LCMV) [ 149 , 171 , 172 ], hepatitis B virus (HBV) [ 173 – 180 ], polycythemia-inducing FV [ 180 ], FluA [ 181 , 182 ], HSV [ 183 ], DENV2 [ 184 , 185 ], and SARS CoV-2 [ 186 – 190 ], EBV [ 191 ]); cancer (colorectal cancer [ 192 – 194 ], NCLC [ 195 ], hepatocellular carcinoma [ 175 , 196 ], hematologic malignancies [ 197 ], pancreatic tumors [ 198 ], gastric cancer [ 199 ], breast cancer [ 200 ], thyroid cancer [ 201 ], melanoma [ 202 ], and lymphoma [ 203 ]); bacterial infection ( Escherichia coli , Acinetobacter baumannii , Klebsiella pneumonia , Pseudomonas aeruginosa , and Staphylococcus aureus [ 204 ]); parasitic infection ( Leishmania mexicana [ 205 ]); immunodeficiency disease (CVID [ 206 ]); autoimmune diseases [ 4 , 131 , 207 – 210 ] (rheumatoid arthritis (RA) [ 131 , 207 ] [ 211 ], primary Sjögren syndrome (pSS) [ 208 ] [ 212 ], and multiple sclerosis (MS) [ 210 , 213 ]).…”